ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

NUTX // Nutex Health Inc.

FA <GO> NASDAQ RQD COCKPIT → CIK 0001479681 ↗
Consumer Discretionary • Business Services
$210.10 ▼ -2.53 (-1.19%)
MKT CAP: $1.44B • VOL: 79.6K
NUTX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
LINE ITEM (USD / %)
FY 2025
FILED 2025-12-31
FY 2024
FILED 2024-12-31
FY 2023
FILED 2023-12-31
Revenue (Total Sales) $875.3M $479.9M $247.6M
YoY Revenue Growth % +82.4% +93.8% —
Gross Profit $444.3M $196.3M —
Gross Margin % 50.8% 40.9% —
Research & Development (R&D) — — —
Operating Income (EBIT) $275.6M $130.7M -$31.8M
Operating Margin % 31.5% 27.2% -12.8%
Net Income (GAAP) $70.8M $52.1M -$45.8M
EBITDA (Normalized) $277.6M $132.5M —
Diluted EPS ($/sh) — — —
Operating Cash Flow (OCF) $248.1M $23.2M $1.3M
Capital Expenditures (CapEx) $2.5M $2.3M —
Free Cash Flow (FCF) $245.6M $20.8M $1.3M
FCF Margin % 28.1% 4.3% 0.5%
Return on Invested Capital (ROIC %) 95.0% 90.4% —
Cash & Short-Term Equivalents $185.6M $40.6M —
Total Debt (Short + Long Term) $29.2M $22.5M —
Total Stockholders' Equity $329.4M $132.4M —